We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Higher Occupancy Help Encompass Health Counter Rising Costs in Q2?
Read MoreHide Full Article
Key Takeaways
EHC is expected to deliver 7.9% revenue growth and 5.7% EPS growth in the second quarter.
Encompass Health's occupancy is projected to rise to 79.9% from 76.6% a year ago.
EHC's total discharges are expected to increase 5.8%, supported by higher patient volumes.
Hospital operator Encompass Health Corporation (EHC - Free Report) is set to report second-quarter 2026 results on Aug. 5, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $1.48 per shareon revenues of $1.57 billion.
The second-quarter earnings estimate has remained stable over the past 60 days. The bottom-line projection indicates a year-over-year increase of 5.7%. Also, the Zacks Consensus Estimate for quarterly revenues suggests year-over-year growth of 7.9%.
Image Source: Zacks Investment Research
For full-year 2026, the Zacks Consensus Estimate for Encompass Health’s revenues is pegged at $6.43 billion, implying a rise of 8.3% year over year. The consensus mark for 2026 earnings per share is pegged at $5.96, indicating a jump of 9.4% on a year-over-year basis.
Encompass Health beat the consensus estimate for earnings in each of the trailing four quarters, with the average surprise being 9.8%, as you can see below.
Encompass Health Corporation Price and EPS Surprise
However, our proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That’s not the case here.
EHC has an Earnings ESP of 0.00% and carries a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
The Zacks Consensus Estimate for Inpatient revenues suggests 7.8% year-over-year growth. Also, the same for Outpatient and other revenues indicates a nearly 8% increase from a year ago. Medicare revenues are expected to grow 8.9% in the second quarter.
Meanwhile, the consensus estimate for total discharges signals a 5.8% year-over-year rise, while our model estimate predicts a 6.7% increase. The consensus mark suggests 1.8% year-over-year growth in net patient revenue per discharge in the second quarter.
The Zacks Consensus Estimate for the number of hospitals is currently pegged at 176, up from 169 a year ago. Both the consensus estimate and our model estimate for occupancy are pegged at 79.9%, up from 76.6% in the year-ago quarter.
The factors stated above are expected to have positioned the company for year-over-year growth in revenues and profits. However, the upside was likely partly offset by elevated operating expenses, particularly due to higher salaries, benefits, and general administrative costs.
How Are EHC’s Peers Doing This Quarter?
Companies in the broader Medical space, like Tenet Healthcare Corporation (THC - Free Report) , The Ensign Group, Inc. (ENSG - Free Report) and Universal Health Services, Inc. (UHS - Free Report) , have already reported their results for the June quarter, and here’s how they have performed.
Tenet Healthcare reported second-quarter 2026 adjusted EPS of $6.12, which surpassed the Zacks Consensus Estimate by 50% and increased 52.2% year over year.The strong quarterly results were driven by strong same-facility revenue growth, higher patient acuity and THC’s disciplined expense management. However, the gains were partly offset by an unfavorable payer mix due to lower exchange admissions.
Ensign reported second-quarter 2026 adjusted EPS of $1.92, which beat the Zacks Consensus Estimate by 6.7% and improved 20.8% year over year. ENSG’s strong results were driven by higher occupancy, improved patient days and contributions from acquired and transitioning facilities, along with growth in rental income. The positives were partly offset by higher expenses.
Universal Health Services reported second-quarter 2026 adjusted EPS of $5.98, which beat the Zacks Consensus Estimate by 5.7%. The bottom line rose 10.1% year over year. The strong quarterly results were driven by healthy revenue growth across both the Acute Care and Behavioral Health segments. Higher adjusted admissions, increased patient days and improved unit revenues on a same-facility basis supported performance in both businesses. However, the upside was partly offset by UHS’ elevated operating costs.
View the Zacks #1 Rank List
Image: Bigstock
Can Higher Occupancy Help Encompass Health Counter Rising Costs in Q2?
Key Takeaways
Hospital operator Encompass Health Corporation (EHC - Free Report) is set to report second-quarter 2026 results on Aug. 5, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $1.48 per shareon revenues of $1.57 billion.
The second-quarter earnings estimate has remained stable over the past 60 days. The bottom-line projection indicates a year-over-year increase of 5.7%. Also, the Zacks Consensus Estimate for quarterly revenues suggests year-over-year growth of 7.9%.
For full-year 2026, the Zacks Consensus Estimate for Encompass Health’s revenues is pegged at $6.43 billion, implying a rise of 8.3% year over year. The consensus mark for 2026 earnings per share is pegged at $5.96, indicating a jump of 9.4% on a year-over-year basis.
Encompass Health beat the consensus estimate for earnings in each of the trailing four quarters, with the average surprise being 9.8%, as you can see below.
Encompass Health Corporation Price and EPS Surprise
Encompass Health Corporation price-eps-surprise | Encompass Health Corporation Quote
Q2 Earnings Whispers for EHC
However, our proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That’s not the case here.
EHC has an Earnings ESP of 0.00% and carries a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
You can see the complete list of today’s Zacks #1 Rank stocks here.
What’s Shaping EHC’s Q2 Results?
The Zacks Consensus Estimate for Inpatient revenues suggests 7.8% year-over-year growth. Also, the same for Outpatient and other revenues indicates a nearly 8% increase from a year ago. Medicare revenues are expected to grow 8.9% in the second quarter.
Meanwhile, the consensus estimate for total discharges signals a 5.8% year-over-year rise, while our model estimate predicts a 6.7% increase. The consensus mark suggests 1.8% year-over-year growth in net patient revenue per discharge in the second quarter.
The Zacks Consensus Estimate for the number of hospitals is currently pegged at 176, up from 169 a year ago. Both the consensus estimate and our model estimate for occupancy are pegged at 79.9%, up from 76.6% in the year-ago quarter.
The factors stated above are expected to have positioned the company for year-over-year growth in revenues and profits. However, the upside was likely partly offset by elevated operating expenses, particularly due to higher salaries, benefits, and general administrative costs.
How Are EHC’s Peers Doing This Quarter?
Companies in the broader Medical space, like Tenet Healthcare Corporation (THC - Free Report) , The Ensign Group, Inc. (ENSG - Free Report) and Universal Health Services, Inc. (UHS - Free Report) , have already reported their results for the June quarter, and here’s how they have performed.
Tenet Healthcare reported second-quarter 2026 adjusted EPS of $6.12, which surpassed the Zacks Consensus Estimate by 50% and increased 52.2% year over year.The strong quarterly results were driven by strong same-facility revenue growth, higher patient acuity and THC’s disciplined expense management. However, the gains were partly offset by an unfavorable payer mix due to lower exchange admissions.
Ensign reported second-quarter 2026 adjusted EPS of $1.92, which beat the Zacks Consensus Estimate by 6.7% and improved 20.8% year over year. ENSG’s strong results were driven by higher occupancy, improved patient days and contributions from acquired and transitioning facilities, along with growth in rental income. The positives were partly offset by higher expenses.
Universal Health Services reported second-quarter 2026 adjusted EPS of $5.98, which beat the Zacks Consensus Estimate by 5.7%. The bottom line rose 10.1% year over year. The strong quarterly results were driven by healthy revenue growth across both the Acute Care and Behavioral Health segments. Higher adjusted admissions, increased patient days and improved unit revenues on a same-facility basis supported performance in both businesses. However, the upside was partly offset by UHS’ elevated operating costs.